Research ArticleCardiovascular
AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Ahmed Alhusban, Anna Kozak, Adviye Ergul and Susan C. Fagan
Journal of Pharmacology and Experimental Therapeutics February 2013, 344 (2) 348-359; DOI: https://doi.org/10.1124/jpet.112.197483
Ahmed Alhusban
Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood, VA Medical Center (A.A., A.K., A.E., S.C.F.), and Departments of Physiology (A.E.) and Neurology (S.C.F.), Georgia Health Sciences University, Augusta, Georgia
Anna Kozak
Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood, VA Medical Center (A.A., A.K., A.E., S.C.F.), and Departments of Physiology (A.E.) and Neurology (S.C.F.), Georgia Health Sciences University, Augusta, Georgia
Adviye Ergul
Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood, VA Medical Center (A.A., A.K., A.E., S.C.F.), and Departments of Physiology (A.E.) and Neurology (S.C.F.), Georgia Health Sciences University, Augusta, Georgia
Susan C. Fagan
Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood, VA Medical Center (A.A., A.K., A.E., S.C.F.), and Departments of Physiology (A.E.) and Neurology (S.C.F.), Georgia Health Sciences University, Augusta, Georgia
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
BDNF Mediates ARBs Angiogenesis
Ahmed Alhusban, Anna Kozak, Adviye Ergul and Susan C. Fagan
Journal of Pharmacology and Experimental Therapeutics February 1, 2013, 344 (2) 348-359; DOI: https://doi.org/10.1124/jpet.112.197483
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement